$2.67
2.20% yesterday
Nasdaq, Jul 14, 10:18 pm CET
ISIN
US56600D1072
Symbol
MRVI

Maravai LifeSciences Stock price

$2.67
+0.51 23.61% 1M
-1.87 41.19% 6M
-2.78 51.01% YTD
-6.09 69.52% 1Y
-22.90 89.56% 3Y
-27.18 91.06% 5Y
-27.18 91.06% 10Y
-27.18 91.06% 20Y
Nasdaq, Closing price Mon, Jul 14 2025
-0.06 2.20%
ISIN
US56600D1072
Symbol
MRVI
Sector
Industry

Key metrics

Basic
Market capitalization
$679.9m
Enterprise Value
$721.5m
Net debt
$41.6m
Cash
$285.1m
Shares outstanding
254.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.8 | 3.4
EV/Sales
3.0 | 3.6
EV/FCF
negative
P/B
2.3
Financial Health
Equity Ratio
32.3%
Return on Equity
-44.5%
ROCE
-9.7%
ROIC
-13.1%
Debt/Equity
1.1
Financials (TTM | estimate)
Revenue
$241.9m | $198.7m
EBITDA
$-86.7m | $-19.1m
EBIT
$-87.3m | $-84.3m
Net Income
$-162.7m | $-74.5m
Free Cash Flow
$-24.2m
Growth (TTM | estimate)
Revenue
-11.8% | -23.3%
EBITDA
-1,725.9% | 72.0%
EBIT
-82.9% | -19.3%
Net Income
-24.2% | 48.6%
Free Cash Flow
21.1%
Margin (TTM | estimate)
Gross
37.3%
EBITDA
-35.9% | -9.6%
EBIT
-36.1%
Net
-67.3% | -37.5%
Free Cash Flow
-10.0%
More
EPS
$-1.2
FCF per Share
$-0.1
Short interest
10.8%
Employees
580
Rev per Employee
$450.0k
Show more

Is Maravai LifeSciences a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,007 stocks worldwide.

Maravai LifeSciences Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Maravai LifeSciences forecast:

11x Buy
61%
7x Hold
39%

Analyst Opinions

18 Analysts have issued a Maravai LifeSciences forecast:

Buy
61%
Hold
39%

Financial data from Maravai LifeSciences

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
242 242
12% 12%
100%
- Direct Costs 152 152
1% 1%
63%
90 90
25% 25%
37%
- Selling and Administrative Expenses 160 160
5% 5%
66%
- Research and Development Expense 19 19
9% 9%
8%
-87 -87
1,726% 1,726%
-36%
- Depreciation and Amortization 0.60 0.60
99% 99%
0%
EBIT (Operating Income) EBIT -87 -87
83% 83%
-36%
Net Profit -163 -163
24% 24%
-67%

In millions USD.

Don't miss a Thing! We will send you all news about Maravai LifeSciences directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Maravai LifeSciences Stock News

Neutral
GlobeNewsWire
about 15 hours ago
Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options
Neutral
GlobeNewsWire
7 days ago
NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) on behalf of long-term stockholders following a class action complaint that was filed against Maravai on March 3, 2025 with a Class Period from August 7, 2024 and February 24, 20...
Neutral
GlobeNewsWire
13 days ago
SAN DIEGO, July 02, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of the following companies: Quantum Computing Inc. (NASDAQ: QUBT), AppLovin Corporation (NASDAQ: APP), Skyworks Solutions, Inc. (NASDAQ: SWKS), and Maravai LifeSciences Holdings Inc. (NASDAQ: MR...
More Maravai LifeSciences News

Company Profile

Maravai Lifesciences Holdings, Inc. operates as an investment holding company. It develops biopharmaceuticals. The company is headquartered in San Diego, CA.

Head office United States
CEO William Martin
Employees 580
Founded 2014
Website www.maravai.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today